Methylprednisolone Completed Phase 2 Trials for Multiple Myeloma and Plasma Cell Neoplasm / Myelodysplastic Syndromes (MDS) / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003960Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer